0.8762
Fibrobiologics Inc (FBLG) 最新ニュース
FY2025 EPS Estimates for FibroBiologics Increased by Analyst - Defense World
FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25… - Yahoo Finance
HC Wainwright Comments on FibroBiologics Q1 Earnings - Defense World
FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt - GlobeNewswire Inc.
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair - GlobeNewswire
FibroBiologics announces advancement in results of brain tissue repair - TipRanks
Fibrobiologics Announces Scientific Advancement In Confirmation Results Of Brain Tissue Repair - MarketScreener
Major Breakthrough: FibroBiologics Confirms Brain Tissue Regeneration Success - Stock Titan
FibroBiologics’ (FBLG) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
Virtu Financial LLC Buys New Holdings in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World
FibroBiologics’ (FBLG) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Fibrobiologics stock plunges to 52-week low at $0.93 amid market challenges By Investing.com - Investing.com South Africa
Fibrobiologics stock plunges to 52-week low at $0.93 amid market challenges - Investing.com India
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics Slashes Annual Losses by $5.3M as Key Clinical Trial Approaches - Stock Titan
Spotting Winners: TopBuild (NYSE:BLD) And Home Builders Stocks In Q4 - The Globe and Mail
FibroBiologics Announces 2025 Annual Meeting of Stockholders - GlobeNewswire
Biotech Pioneer FibroBiologics Reveals Massive 160+ Patent Portfolio at Upcoming Shareholder Meeting - Stock Titan
Applied Industrial (AIT): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
3 Reasons to Avoid FUBO and 1 Stock to Buy Instead - The Globe and Mail
Intuitive Machines Stock (LUNR) Lifts Off with 30% Surge Post Q4 Results - The Globe and Mail
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - GlobeNewswire
FibroBiologics Announces Presentation on Innovative Fibroblast-Based Therapeutics at The German-Nordic Joint Extracellular Matrix Meeting - Nasdaq
FibroBiologics Reveals Groundbreaking Fibroblast Treatment Targeting 7 Major Diseases - Stock Titan
FBLG stock touches 52-week low at $0.98 amid sharp annual decline By Investing.com - Investing.com South Africa
FBLG stock touches 52-week low at $0.98 amid sharp annual decline - Investing.com Australia
Life Sciences Investor Forum Agenda Announced for March 13th - GlobeNewswire
FibroBiologics files patent application for fibroblast-based therapeutics - TipRanks
FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics - GlobeNewswire
Could FibroBiologics' New Mitochondrial Therapy Patent Transform Treatment for Chronic Diseases? - StockTitan
FibroBiologics’ (FBLG) Buy Rating Reiterated at D. Boral Capital - Defense World
FibroBiologics and Charles River Announce Completion and - GlobeNewswire
FibroBiologics and Charles River complete master cell bank for clinical trials - TipRanks
FibroBiologics Completes Master Cell Bank for CYWC628 in Collaboration with Charles River Laboratories - Nasdaq
FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic - GlobeNewswire
Can This New Cell Therapy Breakthrough Finally Solve the Diabetic Foot Ulcer Crisis? - Stock Titan
FibroBiologics (FBLG) Expected to Announce Earnings on Thursday - Defense World
Fibrobiologics stock plunges to 52-week low of $1.04 By Investing.com - Investing.com Australia
Fibrobiologics stock plunges to 52-week low of $1.04 - Investing.com India
FBLG: Analyst Day Provides In-Depth Overview of Pipeline… - Zacks Small Cap Research
FibroBiologics' (FBLG) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
FibroBiologics’ (FBLG) Buy Rating Reiterated at HC Wainwright - Armenian Reporter
Exploring Growth Opportunities In FibroBiologics Inc (NASDAQ: FBLG) - Stocks Register
D. Boral Capital Reaffirms “Buy” Rating for FibroBiologics (NASDAQ:FBLG) - Defense World
Should This Give FibroBiologics Inc (NASDAQ: FBLG) Investors Sleepless Nights? - Stocks Register
FibroBiologics Inc (FBLG) stock analysis: A comprehensive overview - US Post News
FBLG (FibroBiologics Inc) may reap gains as insiders became active recently - Knox Daily
FBLG Stock Price and Chart — NASDAQ:FBLG - TradingView
FibroBiologics issues shares to fulfill commitment fee - MSN
FibroBiologics issues shares to fulfill commitment fee By Investing.com - Investing.com Australia
大文字化:
|
ボリューム (24 時間):